샘플 요청 목록

 카트 문의
시장보고서
상품코드
1866777

발열 냉각 패치 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

Fever Cooling Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 발열 냉각 패치 시장 규모는 2024년에 2억 6,300만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 4.0%로 성장하여 2031년까지 3억 4,600만 달러로 확대될 것으로 예측됩니다.

이 보고서는 발열 냉각 패치의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축에 대한 최근 관세 조정 및 국제 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.

발열 냉각 패치는 발열, 두통, 일광화상, 근육통에 국소적인 냉각 효과를 제공하는 하이드로겔 패치입니다. 부드럽고 피부 친화적인 소재로 이마에 붙여도 잔여물이 남지 않고, 머리카락을 잡아당기지 않습니다. 바로 사용할 수 있고, 약물과 함께 사용해도 안전하며, 8시간 동안 냉각 효과가 지속됩니다.

2024년 발열 냉각 패치의 전 세계 출하량은 11억 8,000만 장을 넘어섰고, 평균 공장 출하 가격은 장당 약 0.22달러였습니다.

북미의 쿨링 패치 시장은 비교적 성숙한 시장으로, 일반의약품(OTC) 헬스케어 제품, 특히 어린이를 위한 비약물적 해열요법에 대한 소비자 선호도가 수요를 주도하고 있습니다. 미국과 캐나다에서는 약국, 슈퍼마켓, 온라인 플랫폼을 통해 안정적인 소비가 이루어지고 있습니다. 냉각시간 연장, 피부 친화적인 하이드로겔 소재 등 제품 혁신이 경쟁력 유지에 기여하고 있습니다. 재택의료와 자가 치료 트렌드에 대한 인식이 높아진 것도 시장 성장에 힘을 실어주고 있습니다.

유럽에서는 강력한 OTC 의료 문화와 엄격한 제품 품질 기준이 발열 냉각 패치에 대한 수요를 뒷받침하고 있습니다. 독일, 프랑스, 영국 등의 국가에서는 안정적인 판매량을 보이며, 자녀의 온화한 발열 관리를 원하는 보호자층에서 높은 보급률을 보이고 있습니다. 그러나 의료기기 표시 및 제품 안전에 대한 규제 요건은 신규 브랜드의 진입 장벽을 높이고 있습니다. 온라인 판매 확대와 성인 건강 관리 부문으로의 확장에 성장 기회가 존재합니다.

아시아태평양은 높은 인구 밀도, 소비자의 높은 수용성, 소아 및 성인 모두에 대한 광범위한 사용으로 인해 냉각 패치 시장에서 가장 크고 빠르게 성장하는 시장입니다. 중국은 대규모 국내 제조업체와 광범위한 소매 유통망에 힘입어 생산과 소비 양면에서 선도적인 위치에 있습니다. 일본과 한국은 첨단 하이드로겔 기술로 강력한 브랜드 인지도를 보이고 있으며, 동남아시아 국가에서는 약국이나 편의점을 통한 빠른 보급이 이루어지고 있습니다. E-Commerce의 보급률 향상도 성장을 더욱 촉진하고 있습니다.

라틴아메리카, 중동 및 아프리카와 같은 다른 지역에서는 발열 냉각 패치 시장이 여전히 개발 초기 단계에 있습니다. 의료 인식의 증가, 소매 네트워크의 확대, 비약물 해열 방법의 점진적인 채택이 성장을 뒷받침하고 있습니다. 그러나 소비자의 낮은 구매력과 제한된 브랜드 선택권이 급속한 확장을 제약하고 있습니다.

이 보고서는 발열 냉각 패치 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역 및 국가, 유형 및 판매 채널별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 2031년까지의 예측 데이터를 포함하는 판매량(백만 개) 및 매출액(백만 달러)으로 발열 냉각 패치 시장의 규모, 추정 및 예측을 제시합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장 내 자사 포지셔닝 분석, 그리고 열병합발전소 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

  • Kobayashi Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Pigeon
  • New Tac Kasei
  • DIA Pharmaceutical
  • Towa Pharmaceutical
  • Hadariki Plus
  • Sato Pharmaceutical
  • Lion
  • 3M
  • Unexo Life Sciences
  • Teh Seng Pharmaceutical
  • Zhuhai Guojia
  • Cofoe Medical
  • Qingdao Hainuo
  • Zhejiang Yinda Biotechnology
  • Fuso Teiyaku(Qingdao)
  • Foshan Aqua Gel Biotech
  • Jinhua Jingdi Medical
  • Kangbijian Group
  • Henan Chaoya
  • Foshan Kincn

유형별 부문

  • 유아
  • 아동
  • 성인

성분별 부문

  • 민트 성분
  • 민트 미사용 성분

판매 채널별 부문

  • 온라인 판매
  • 오프라인 판매

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSM 25.11.27

자주 묻는 질문

  • 발열 냉각 패치 시장 규모는 어떻게 예측되나요?
  • 2024년 발열 냉각 패치의 전 세계 출하량은 얼마인가요?
  • 북미 시장에서 발열 냉각 패치의 소비는 어떻게 이루어지고 있나요?
  • 유럽에서 발열 냉각 패치의 수요를 뒷받침하는 요소는 무엇인가요?
  • 아시아태평양 지역의 발열 냉각 패치 시장은 어떤 특징이 있나요?
  • 발열 냉각 패치 시장의 주요 기업은 어디인가요?

The global market for Fever Cooling Patch was estimated to be worth US$ 263 million in 2024 and is forecast to a readjusted size of US$ 346 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fever Cooling Patch cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fever Cooling Patch is a hydrogel patch providing targeted cooling relief from fever, headache, sunburn, and muscle pain. The patch contains a soft, gentle and skin-friendly material that sticks to the forehead without leaving any residue and pulling hair. It is ready to use and safe to use with medication also gives an 8 hours of cooling effect.

The global shipment of fever cooling patches in 2024 exceeded 1.18 billion Pcs, with an average factory price of approximately $0.22 per piece.

The North American fever cooling patch market is relatively mature, with demand driven by over-the-counter (OTC) healthcare products and consumer preference for non-medicated fever relief, especially for children. The United States and Canada see stable consumption through pharmacies, supermarkets, and online platforms. Product innovation, such as longer cooling duration and skin-friendly hydrogel materials, helps maintain competitiveness. The market also benefits from heightened awareness of home healthcare and self-medication trends.

In Europe, demand for fever cooling patches is supported by a strong OTC healthcare culture and strict product quality standards. Countries like Germany, France, and the UK show steady sales, with higher penetration among parents seeking gentle fever management for children. However, regulatory requirements on medical device labeling and product safety create higher entry barriers for new brands. Growth opportunities exist in expanding online sales and targeting adult wellness segments.

The Asia-Pacific region is the largest and fastest-growing market for fever cooling patches, driven by high population density, strong consumer acceptance, and widespread use in both children and adults. China leads in both production and consumption, supported by large-scale domestic manufacturers and extensive retail distribution. Japan and South Korea have strong brand presence with advanced hydrogel technologies, while Southeast Asian countries show rapid uptake through pharmacies and convenience stores. Increasing e-commerce penetration further fuels growth.

In other regions, such as Latin America, the Middle East, and Africa, the fever cooling patch market remains in an early development stage. Growth is supported by increasing healthcare awareness, expanding retail networks, and gradual adoption of non-medicated fever relief methods. However, lower consumer purchasing power and limited brand availability constrain rapid expansion.

This report aims to provide a comprehensive presentation of the global market for Fever Cooling Patch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fever Cooling Patch by region & country, by Type, and by Sales Channels.

The Fever Cooling Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fever Cooling Patch.

Market Segmentation

By Company

  • Kobayashi Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Pigeon
  • New Tac Kasei
  • DIA Pharmaceutical
  • Towa Pharmaceutical
  • Hadariki Plus
  • Sato Pharmaceutical
  • Lion
  • 3M
  • Unexo Life Sciences
  • Teh Seng Pharmaceutical
  • Zhuhai Guojia
  • Cofoe Medical
  • Qingdao Hainuo
  • Zhejiang Yinda Biotechnology
  • Fuso Teiyaku (Qingdao)
  • Foshan Aqua Gel Biotech
  • Jinhua Jingdi Medical
  • Kangbijian Group
  • Henan Chaoya
  • Foshan Kincn

Segment by Type

  • Baby
  • Children
  • Adult

Segment by Ingredient

  • Mint Ingredient
  • Mint-free Ingredient

Segment by Sales Channels

  • Online Sales
  • Offline Sales

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fever Cooling Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Sales Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fever Cooling Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fever Cooling Patch in country level. It provides sigmate data by Type, and by Sales Channels for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fever Cooling Patch Product Introduction
  • 1.2 Global Fever Cooling Patch Market Size Forecast
    • 1.2.1 Global Fever Cooling Patch Sales Value (2020-2031)
    • 1.2.2 Global Fever Cooling Patch Sales Volume (2020-2031)
    • 1.2.3 Global Fever Cooling Patch Sales Price (2020-2031)
  • 1.3 Fever Cooling Patch Market Trends & Drivers
    • 1.3.1 Fever Cooling Patch Industry Trends
    • 1.3.2 Fever Cooling Patch Market Drivers & Opportunity
    • 1.3.3 Fever Cooling Patch Market Challenges
    • 1.3.4 Fever Cooling Patch Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fever Cooling Patch Players Revenue Ranking (2024)
  • 2.2 Global Fever Cooling Patch Revenue by Company (2020-2025)
  • 2.3 Global Fever Cooling Patch Players Sales Volume Ranking (2024)
  • 2.4 Global Fever Cooling Patch Sales Volume by Company Players (2020-2025)
  • 2.5 Global Fever Cooling Patch Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Fever Cooling Patch Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Fever Cooling Patch Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Fever Cooling Patch
  • 2.9 Fever Cooling Patch Market Competitive Analysis
    • 2.9.1 Fever Cooling Patch Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Fever Cooling Patch Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fever Cooling Patch as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Baby
    • 3.1.2 Children
    • 3.1.3 Adult
  • 3.2 Global Fever Cooling Patch Sales Value by Type
    • 3.2.1 Global Fever Cooling Patch Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fever Cooling Patch Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fever Cooling Patch Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Fever Cooling Patch Sales Volume by Type
    • 3.3.1 Global Fever Cooling Patch Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Fever Cooling Patch Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Fever Cooling Patch Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Fever Cooling Patch Average Price by Type (2020-2031)

4 Segmentation by Ingredient

  • 4.1 Introduction by Ingredient
    • 4.1.1 Mint Ingredient
    • 4.1.2 Mint-free Ingredient
  • 4.2 Global Fever Cooling Patch Sales Value by Ingredient
    • 4.2.1 Global Fever Cooling Patch Sales Value by Ingredient (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fever Cooling Patch Sales Value, by Ingredient (2020-2031)
    • 4.2.3 Global Fever Cooling Patch Sales Value, by Ingredient (%) (2020-2031)
  • 4.3 Global Fever Cooling Patch Sales Volume by Ingredient
    • 4.3.1 Global Fever Cooling Patch Sales Volume by Ingredient (2020 VS 2024 VS 2031)
    • 4.3.2 Global Fever Cooling Patch Sales Volume, by Ingredient (2020-2031)
    • 4.3.3 Global Fever Cooling Patch Sales Volume, by Ingredient (%) (2020-2031)
  • 4.4 Global Fever Cooling Patch Average Price by Ingredient (2020-2031)

5 Segmentation by Sales Channels

  • 5.1 Introduction by Sales Channels
    • 5.1.1 Online Sales
    • 5.1.2 Offline Sales
  • 5.2 Global Fever Cooling Patch Sales Value by Sales Channels
    • 5.2.1 Global Fever Cooling Patch Sales Value by Sales Channels (2020 VS 2024 VS 2031)
    • 5.2.2 Global Fever Cooling Patch Sales Value, by Sales Channels (2020-2031)
    • 5.2.3 Global Fever Cooling Patch Sales Value, by Sales Channels (%) (2020-2031)
  • 5.3 Global Fever Cooling Patch Sales Volume by Sales Channels
    • 5.3.1 Global Fever Cooling Patch Sales Volume by Sales Channels (2020 VS 2024 VS 2031)
    • 5.3.2 Global Fever Cooling Patch Sales Volume, by Sales Channels (2020-2031)
    • 5.3.3 Global Fever Cooling Patch Sales Volume, by Sales Channels (%) (2020-2031)
  • 5.4 Global Fever Cooling Patch Average Price by Sales Channels (2020-2031)

6 Segmentation by Region

  • 6.1 Global Fever Cooling Patch Sales Value by Region
    • 6.1.1 Global Fever Cooling Patch Sales Value by Region: 2020 VS 2024 VS 2031
    • 6.1.2 Global Fever Cooling Patch Sales Value by Region (2020-2025)
    • 6.1.3 Global Fever Cooling Patch Sales Value by Region (2026-2031)
    • 6.1.4 Global Fever Cooling Patch Sales Value by Region (%), (2020-2031)
  • 6.2 Global Fever Cooling Patch Sales Volume by Region
    • 6.2.1 Global Fever Cooling Patch Sales Volume by Region: 2020 VS 2024 VS 2031
    • 6.2.2 Global Fever Cooling Patch Sales Volume by Region (2020-2025)
    • 6.2.3 Global Fever Cooling Patch Sales Volume by Region (2026-2031)
    • 6.2.4 Global Fever Cooling Patch Sales Volume by Region (%), (2020-2031)
  • 6.3 Global Fever Cooling Patch Average Price by Region (2020-2031)
  • 6.4 North America
    • 6.4.1 North America Fever Cooling Patch Sales Value, 2020-2031
    • 6.4.2 North America Fever Cooling Patch Sales Value by Country (%), 2024 VS 2031
  • 6.5 Europe
    • 6.5.1 Europe Fever Cooling Patch Sales Value, 2020-2031
    • 6.5.2 Europe Fever Cooling Patch Sales Value by Country (%), 2024 VS 2031
  • 6.6 Asia Pacific
    • 6.6.1 Asia Pacific Fever Cooling Patch Sales Value, 2020-2031
    • 6.6.2 Asia Pacific Fever Cooling Patch Sales Value by Region (%), 2024 VS 2031
  • 6.7 South America
    • 6.7.1 South America Fever Cooling Patch Sales Value, 2020-2031
    • 6.7.2 South America Fever Cooling Patch Sales Value by Country (%), 2024 VS 2031
  • 6.8 Middle East & Africa
    • 6.8.1 Middle East & Africa Fever Cooling Patch Sales Value, 2020-2031
    • 6.8.2 Middle East & Africa Fever Cooling Patch Sales Value by Country (%), 2024 VS 2031

7 Segmentation by Key Countries/Regions

  • 7.1 Key Countries/Regions Fever Cooling Patch Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 7.2 Key Countries/Regions Fever Cooling Patch Sales Value and Sales Volume
    • 7.2.1 Key Countries/Regions Fever Cooling Patch Sales Value, 2020-2031
    • 7.2.2 Key Countries/Regions Fever Cooling Patch Sales Volume, 2020-2031
  • 7.3 United States
    • 7.3.1 United States Fever Cooling Patch Sales Value, 2020-2031
    • 7.3.2 United States Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.3.3 United States Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.4 Europe
    • 7.4.1 Europe Fever Cooling Patch Sales Value, 2020-2031
    • 7.4.2 Europe Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.4.3 Europe Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.5 China
    • 7.5.1 China Fever Cooling Patch Sales Value, 2020-2031
    • 7.5.2 China Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.5.3 China Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.6 Japan
    • 7.6.1 Japan Fever Cooling Patch Sales Value, 2020-2031
    • 7.6.2 Japan Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.6.3 Japan Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.7 South Korea
    • 7.7.1 South Korea Fever Cooling Patch Sales Value, 2020-2031
    • 7.7.2 South Korea Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.7.3 South Korea Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.8 Southeast Asia
    • 7.8.1 Southeast Asia Fever Cooling Patch Sales Value, 2020-2031
    • 7.8.2 Southeast Asia Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.8.3 Southeast Asia Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031
  • 7.9 India
    • 7.9.1 India Fever Cooling Patch Sales Value, 2020-2031
    • 7.9.2 India Fever Cooling Patch Sales Value by Type (%), 2024 VS 2031
    • 7.9.3 India Fever Cooling Patch Sales Value by Sales Channels, 2024 VS 2031

8 Company Profiles

  • 8.1 Kobayashi Pharmaceutical
    • 8.1.1 Kobayashi Pharmaceutical Company Information
    • 8.1.2 Kobayashi Pharmaceutical Introduction and Business Overview
    • 8.1.3 Kobayashi Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.1.4 Kobayashi Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.1.5 Kobayashi Pharmaceutical Recent Development
  • 8.2 Hisamitsu Pharmaceutical
    • 8.2.1 Hisamitsu Pharmaceutical Company Information
    • 8.2.2 Hisamitsu Pharmaceutical Introduction and Business Overview
    • 8.2.3 Hisamitsu Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.2.4 Hisamitsu Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.2.5 Hisamitsu Pharmaceutical Recent Development
  • 8.3 Pigeon
    • 8.3.1 Pigeon Company Information
    • 8.3.2 Pigeon Introduction and Business Overview
    • 8.3.3 Pigeon Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.3.4 Pigeon Fever Cooling Patch Product Offerings
    • 8.3.5 Pigeon Recent Development
  • 8.4 New Tac Kasei
    • 8.4.1 New Tac Kasei Company Information
    • 8.4.2 New Tac Kasei Introduction and Business Overview
    • 8.4.3 New Tac Kasei Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.4.4 New Tac Kasei Fever Cooling Patch Product Offerings
    • 8.4.5 New Tac Kasei Recent Development
  • 8.5 DIA Pharmaceutical
    • 8.5.1 DIA Pharmaceutical Company Information
    • 8.5.2 DIA Pharmaceutical Introduction and Business Overview
    • 8.5.3 DIA Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.5.4 DIA Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.5.5 DIA Pharmaceutical Recent Development
  • 8.6 Towa Pharmaceutical
    • 8.6.1 Towa Pharmaceutical Company Information
    • 8.6.2 Towa Pharmaceutical Introduction and Business Overview
    • 8.6.3 Towa Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.6.4 Towa Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.6.5 Towa Pharmaceutical Recent Development
  • 8.7 Hadariki Plus
    • 8.7.1 Hadariki Plus Company Information
    • 8.7.2 Hadariki Plus Introduction and Business Overview
    • 8.7.3 Hadariki Plus Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.7.4 Hadariki Plus Fever Cooling Patch Product Offerings
    • 8.7.5 Hadariki Plus Recent Development
  • 8.8 Sato Pharmaceutical
    • 8.8.1 Sato Pharmaceutical Company Information
    • 8.8.2 Sato Pharmaceutical Introduction and Business Overview
    • 8.8.3 Sato Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.8.4 Sato Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.8.5 Sato Pharmaceutical Recent Development
  • 8.9 Lion
    • 8.9.1 Lion Company Information
    • 8.9.2 Lion Introduction and Business Overview
    • 8.9.3 Lion Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.9.4 Lion Fever Cooling Patch Product Offerings
    • 8.9.5 Lion Recent Development
  • 8.10 3M
    • 8.10.1 3M Company Information
    • 8.10.2 3M Introduction and Business Overview
    • 8.10.3 3M Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.10.4 3M Fever Cooling Patch Product Offerings
    • 8.10.5 3M Recent Development
  • 8.11 Unexo Life Sciences
    • 8.11.1 Unexo Life Sciences Company Information
    • 8.11.2 Unexo Life Sciences Introduction and Business Overview
    • 8.11.3 Unexo Life Sciences Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.11.4 Unexo Life Sciences Fever Cooling Patch Product Offerings
    • 8.11.5 Unexo Life Sciences Recent Development
  • 8.12 Teh Seng Pharmaceutical
    • 8.12.1 Teh Seng Pharmaceutical Company Information
    • 8.12.2 Teh Seng Pharmaceutical Introduction and Business Overview
    • 8.12.3 Teh Seng Pharmaceutical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.12.4 Teh Seng Pharmaceutical Fever Cooling Patch Product Offerings
    • 8.12.5 Teh Seng Pharmaceutical Recent Development
  • 8.13 Zhuhai Guojia
    • 8.13.1 Zhuhai Guojia Company Information
    • 8.13.2 Zhuhai Guojia Introduction and Business Overview
    • 8.13.3 Zhuhai Guojia Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.13.4 Zhuhai Guojia Fever Cooling Patch Product Offerings
    • 8.13.5 Zhuhai Guojia Recent Development
  • 8.14 Cofoe Medical
    • 8.14.1 Cofoe Medical Company Information
    • 8.14.2 Cofoe Medical Introduction and Business Overview
    • 8.14.3 Cofoe Medical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.14.4 Cofoe Medical Fever Cooling Patch Product Offerings
    • 8.14.5 Cofoe Medical Recent Development
  • 8.15 Qingdao Hainuo
    • 8.15.1 Qingdao Hainuo Company Information
    • 8.15.2 Qingdao Hainuo Introduction and Business Overview
    • 8.15.3 Qingdao Hainuo Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.15.4 Qingdao Hainuo Fever Cooling Patch Product Offerings
    • 8.15.5 Qingdao Hainuo Recent Development
  • 8.16 Zhejiang Yinda Biotechnology
    • 8.16.1 Zhejiang Yinda Biotechnology Company Information
    • 8.16.2 Zhejiang Yinda Biotechnology Introduction and Business Overview
    • 8.16.3 Zhejiang Yinda Biotechnology Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.16.4 Zhejiang Yinda Biotechnology Fever Cooling Patch Product Offerings
    • 8.16.5 Zhejiang Yinda Biotechnology Recent Development
  • 8.17 Fuso Teiyaku (Qingdao)
    • 8.17.1 Fuso Teiyaku (Qingdao) Company Information
    • 8.17.2 Fuso Teiyaku (Qingdao) Introduction and Business Overview
    • 8.17.3 Fuso Teiyaku (Qingdao) Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.17.4 Fuso Teiyaku (Qingdao) Fever Cooling Patch Product Offerings
    • 8.17.5 Fuso Teiyaku (Qingdao) Recent Development
  • 8.18 Foshan Aqua Gel Biotech
    • 8.18.1 Foshan Aqua Gel Biotech Company Information
    • 8.18.2 Foshan Aqua Gel Biotech Introduction and Business Overview
    • 8.18.3 Foshan Aqua Gel Biotech Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.18.4 Foshan Aqua Gel Biotech Fever Cooling Patch Product Offerings
    • 8.18.5 Foshan Aqua Gel Biotech Recent Development
  • 8.19 Jinhua Jingdi Medical
    • 8.19.1 Jinhua Jingdi Medical Company Information
    • 8.19.2 Jinhua Jingdi Medical Introduction and Business Overview
    • 8.19.3 Jinhua Jingdi Medical Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.19.4 Jinhua Jingdi Medical Fever Cooling Patch Product Offerings
    • 8.19.5 Jinhua Jingdi Medical Recent Development
  • 8.20 Kangbijian Group
    • 8.20.1 Kangbijian Group Company Information
    • 8.20.2 Kangbijian Group Introduction and Business Overview
    • 8.20.3 Kangbijian Group Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.20.4 Kangbijian Group Fever Cooling Patch Product Offerings
    • 8.20.5 Kangbijian Group Recent Development
  • 8.21 Henan Chaoya
    • 8.21.1 Henan Chaoya Company Information
    • 8.21.2 Henan Chaoya Introduction and Business Overview
    • 8.21.3 Henan Chaoya Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.21.4 Henan Chaoya Fever Cooling Patch Product Offerings
    • 8.21.5 Henan Chaoya Recent Development
  • 8.22 Foshan Kincn
    • 8.22.1 Foshan Kincn Company Information
    • 8.22.2 Foshan Kincn Introduction and Business Overview
    • 8.22.3 Foshan Kincn Fever Cooling Patch Sales, Revenue, Price and Gross Margin (2020-2025)
    • 8.22.4 Foshan Kincn Fever Cooling Patch Product Offerings
    • 8.22.5 Foshan Kincn Recent Development

9 Industry Chain Analysis

  • 9.1 Fever Cooling Patch Industrial Chain
  • 9.2 Fever Cooling Patch Upstream Analysis
    • 9.2.1 Key Raw Materials
    • 9.2.2 Raw Materials Key Suppliers
    • 9.2.3 Manufacturing Cost Structure
  • 9.3 Midstream Analysis
  • 9.4 Downstream Analysis (Customers Analysis)
  • 9.5 Sales Model and Sales Channels
    • 9.5.1 Fever Cooling Patch Sales Model
    • 9.5.2 Sales Channel
    • 9.5.3 Fever Cooling Patch Distributors

10 Research Findings and Conclusion

11 Appendix

  • 11.1 Research Methodology
    • 11.1.1 Methodology/Research Approach
      • 11.1.1.1 Research Programs/Design
      • 11.1.1.2 Market Size Estimation
      • 11.1.1.3 Market Breakdown and Data Triangulation
    • 11.1.2 Data Source
      • 11.1.2.1 Secondary Sources
      • 11.1.2.2 Primary Sources
  • 11.2 Author Details
  • 11.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제